Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea
Status:
Terminated
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
When patients in hospitals receive antibiotics they often develop diarrhoea. The consequences
may be grave for the patient. Thus far, no preventive measure is available. The investigators
hypothesize that the apathogenic yeast Saccharomyces boulardii, administered in addition to
the antibiotic, may prevent episodes of diarrhoea or may lead to less pronounced diarrhoea.
To test this hypothesis, the investigators are carrying out a clinical trial in 1520 adult
patients in several hospitals.